We welcome our next speaker in our seminar series, Dr. Charles Gawad from Stanford University where he is a Clinical Instructor in Pediatric Hematology and Oncology. His lab works at the interface of biotechnology, computational biology, cellular biology, and clinical medicine. They take pride in their ability to think creatively to devise innovative solutions to challenging biological questions. They are focused on studying how the genomes of individual cells evolve when placed under selection pressure, and aim to understand how that genetic diversity contributes to human health and disease.
Charles Gawad was an Assistant Member in the Departments of Oncology and Computational Biology at St. Jude Children’s Research Hospital. He completed his undergraduate degrees at Arizona State University and his medical degree at the University of Arizona, during which he spent a year as an HHMI-NIH Research Scholar studying the role of BRAF in melanoma. He then completed training in pediatrics at UCLA, followed by pediatric hematology-oncology training at Stanford, during which he completed his PhD in Cancer Biology in Patrick O. Brown’s lab as part of the Advanced Residency Training at Stanford (ARTS) where they unexpectedly found circular RNA is an abundant new class of noncoding RNA. Chuck then completed postdoctoral training in Stephen Quake’s group where they developed novel strategies for determining the evolutionary histories of cancers using single-cell genomics, and his lab now focuses on combining sequencing with novel biochemical and computational methods to more deeply understand the development and treatment resistance of cancer. Chuck is a recipient of an NIH Director’s New Innovator Award, as well as a Burroughs Wellcome Fund Career Award for Medical Scientists. He was also a Leukemia and Lymphoma Society Special Fellow, Hyundai Foundation for Pediatric Research Scholar, and American Society of Hematology Scholar.